ConductScience.org, home

Paper41301080

Bridging Discovery and Treatment: Cancer Biomarker.

Liu H and 3 others. Cancers (Basel), 2025. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Bridging Discovery and Treatment: Cancer Biomarker. Papers, record 41301080. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301080

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bridging Discovery and Treatment: Cancer Biomarker.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
4.67, provisional
iCite
Revised in PubMed
2026-09-25
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu HHengruihttps://orcid.org/0000-0002-5369-3926
2Karsidag IIlayda
3Golin RRebecca
4Wu GGuangzhenhttps://orcid.org/0009-0001-9007-151X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References149

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135058359Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation.Proc Natl Acad Sci U S A2022https://conductscience.org/library/papers/35058359PubMed
237814010Targeting pancreatic cancer metabolic dependencies through glutamine antagonism.Nat Cancer2024https://conductscience.org/library/papers/37814010PubMed
340827204Topology-aware pathway analysis of spatial transcriptomics.PeerJ2025https://conductscience.org/library/papers/40827204PubMed
434678434Tumor perivascular cell-derived extracellular vesicles promote angiogenesis via the Gas6/Axl pathway.Cancer Lett2022https://conductscience.org/library/papers/34678434PubMed
534571995D-2-Hydroxyglutarate in Glioma Biology.Cells2021https://conductscience.org/library/papers/34571995PubMed
625491647Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer.BMC Cancer2014https://conductscience.org/library/papers/25491647PubMed
724875653Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.J Natl Cancer Inst2014https://conductscience.org/library/papers/24875653PubMed
821712485Prognostic impact of phosphorylated HER-2 in HER-2+ primary breast cancer.Oncologist2011https://conductscience.org/library/papers/21712485PubMed
934392831ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer.Breast Cancer Res2021https://conductscience.org/library/papers/34392831PubMed
1022327623RET, ROS1 and ALK fusions in lung cancer.Nat Med2012https://conductscience.org/library/papers/22327623PubMed
1132554709ctDNA monitoring using patient-specific sequencing and integration of variant reads.Sci Transl Med2020https://conductscience.org/library/papers/32554709PubMed
1232306807Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice.Xenobiotica2020https://conductscience.org/library/papers/32306807PubMed
1328582845Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments.Cancer Biomark2017https://conductscience.org/library/papers/28582845PubMed
1432767659DNA in extracellular vesicles: biological and clinical aspects.Mol Oncol2021https://conductscience.org/library/papers/32767659PubMed
1521889194BET bromodomain inhibition as a therapeutic strategy to target c-Myc.Cell2011https://conductscience.org/library/papers/21889194PubMed
1634735635Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients.Curr Oncol Rep2021https://conductscience.org/library/papers/34735635PubMed
1737124524Metabonomic analysis of tumor microenvironments: a mini-review.Front Oncol2023https://conductscience.org/library/papers/37124524PubMed
1832111602Plasma DNA End-Motif Profiling as a Fragmentomic Marker in Cancer, Pregnancy, and Transplantation.Cancer Discov2020https://conductscience.org/library/papers/32111602PubMed
1933842353Dynamic cfDNA Analysis by NGS in EGFR T790M-Positive Advanced NSCLC Patients Failed to the First-Generation EGFR-TKIs.Front Oncol2021https://conductscience.org/library/papers/33842353PubMed
2040299851Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer.Cancer Discov2025https://conductscience.org/library/papers/40299851PubMed

See all 149 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42866441Core needle biopsy washout biomarkers combined with ultrasound for preoperative axillary risk stratification in breast cancer: a retrospective nomogram study with temporal validation.Gland Surg2026https://conductscience.org/library/papers/42866441PubMed
42769460From Tumor Biology to Clinical Perspectives: Novel Biomarkers and Therapeutic Insights in Gastric Cancer.Oncol Res2026https://conductscience.org/library/papers/42769460PubMed
42755971Functional outcomes and biochemical control after radical prostatectomy versus irreversible electroporation for localized prostate cancer.iScience2026https://conductscience.org/library/papers/42755971PubMed
42625235Targeting RASL12 by miR-6791-5p fuels malignant progression in lung adenocarcinoma.Hereditas2026https://conductscience.org/library/papers/42625235PubMed
42558819Stromal Laminin Subunit Alpha 3 is a Novel Prognostic Marker for Breast Cancer.Clin Med Insights Oncol2026https://conductscience.org/library/papers/42558819PubMed
42539880Targeting tumor transition windows.Explor Target Antitumor Ther2026https://conductscience.org/library/papers/42539880PubMed
42510154The Association Between Neutrophil-to-Lymphocyte Ratio and Histological Tumor Differentiation in Solid Malignancies: A Systematic Review.Diagnostics (Basel)2026https://conductscience.org/library/papers/42510154PubMed
42449743A Simulation-Based Stress-Testing Framework for Evaluating the Transportability of Imaging-Derived Logistic Risk Models Across Cutaneous Lesion Phenotypes.Diagnostics (Basel)2026https://conductscience.org/library/papers/42449743PubMed
42423852The role of artificial intelligence in precision medicine for breast cancer.Discov Oncol2026https://conductscience.org/library/papers/42423852PubMed
42416401More than alternative estrogen receptors: the emerging role of GPER-1 and ERα36 in breast cancer.Explor Target Antitumor Ther2026https://conductscience.org/library/papers/42416401PubMed
42352240Translational Perspectives on Cell-Free Mitochondrial DNA as a Biomarker in Gynecological Cancers: Current Limitations and Future Research Directions.Biomolecules2026https://conductscience.org/library/papers/42352240PubMed
42346225Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology Network.Curr Oncol2026https://conductscience.org/library/papers/42346225PubMed
42201477Bioinformatics analysis and preliminary clinical validation of ITGA9 and NPTX2 as prognosis-related genes in acute myeloid leukemia.Discov Oncol2026https://conductscience.org/library/papers/42201477PubMed
42192906Artificial Intelligence in Oncology: A Comprehensive Cross-Cancer Translational Readiness Analysis Across 18 Malignancies.Cancers (Basel)2026https://conductscience.org/library/papers/42192906PubMed
42164390Machine learning integration of multi-omics data develops a sarcomatoid-related renal cell carcinoma score (SARS) for prognosis stratification and guiding therapy.Transl Androl Urol2026https://conductscience.org/library/papers/42164390PubMed
42122230Rethinking Advanced Renal Cell Carcinoma: Integrative Genomics, Immunotherapy, and Molecular-Orthomolecular Strategies.Cancers (Basel)2026https://conductscience.org/library/papers/42122230PubMed
42074564Non-Coding RNAs in Cancer: Decoding Regulatory Networks for Liquid Biopsy Applications.Genes (Basel)2026https://conductscience.org/library/papers/42074564PubMed
42029556High uPAR and Low miR-221 Expression Predict Poor Disease-Free Survival in Triple-Negative Breast Cancer.Pathophysiology2026https://conductscience.org/library/papers/42029556PubMed
41838687Multiple omics analyses and experiments validation identify PRDX3 as a biomarker of prognosis and antioncogene in kidney clear cell carcinoma.PLoS One2026https://conductscience.org/library/papers/41838687PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41301080

GET https://conductscience.org/api/papers/v1/41301080/references?page=2